Create Medical Trial

How to Register Your Study - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/manage-recs/how-register

Basics About Clinical Trials | FDA

https://www.fda.gov/patients/clinical-trials-what-patients-need-know/basics-about-clinical-trials

Clinical trials are conducted according to a plan, called a protocol, which describes: the types of patients who may enter the study the schedules of tests and procedures the …

Adjuvant Capecitabine for Breast Cancer …

https://www.nejm.org/doi/full/10.1056/NEJMoa1612645

Trial Design and Oversight The trial treatments were standard postsurgical treatments, 3,4 which included …

Clinical trials - Merck.com

https://www.merck.com/research/clinical-trials/

For patients with a serious or life-threatening disease who are ineligible or unable to participate in a clinical trial, use of an expanded access program may be an option. …

CREATE: Cross-tumoral Phase 2 With Crizotinib …

https://clinicaltrials.gov/ct2/show/NCT01524926

CREATE: Cross-tumoral Phase 2 With Crizotinib (CREATE) The safety and scientific validity of this study is the responsibility of the study sponsor and …

Clinical Trials | CREATE - Cancer Research and Therapies of …

http://createcancercare.com/Protocols/

The Cancer Research and Therapies of Excellence (CREATE) funded by a grant from the American Society of Clinical Oncologists Conquer Cancer Foundation provides …

Free Clinical Trial Templates | Smartsheet

https://www.smartsheet.com/content/clinical-trial-templates-samples

Your timeline should include these steps: Choose Research Questions and Study Design: Research always begins with questions. Your research question will …

Landmark Trials in Anemia & Kidney …

https://www.renalfellow.org/2020/02/19/landmark-trials-in-anemia-kidney-disease/

Here, we will review the four major trials which illustrate the history of ESAs (NHCT, CREATE, CHOIR, and TREAT), along with a discussion of the newer strategies …

Adjuvant Capecitabine for Breast Cancer after …

https://www.nejm.org/doi/pdf/10.1056/NEJMoa1612645?articleTools=true

The trial was designed by the lead authors and monitored by an independent data and safety monitoring committee. All the patients provided written informed consent. The trial …

CREATE-X a role for capecitabine in early-stage breast …

https://pubmed.ncbi.nlm.nih.gov/28758147/

Results from CREATE-X, showed that capecitabine had a statistically significant survival advantage compared with no additional therapy. This perspective …